Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4

Immunology

Volumn 118, Issue 1, 2006, Pages 50-57

  Redchenko, Irina ^a   Harrop, Richard ^a   Ryan, Matthew G ^a   Hawkins, Robert E ^b   Carroll, Miles W ^c  

^a OXFORD BIOMEDICA UK LTD   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c Science and Technology Centre   (United Kingdom)

Author keywords

CD8 T lymphocytes; ELISPOT (enzyme linked immunospot) assay; Epitope peptide; Human; Tumour associated antigen

Indexed keywords

5T4 PROTEIN; CD4 ANTIGEN; CHROMIUM 51; EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN; HUMAN LEUKOCYTE ANTIGEN CW7; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE DERIVATIVE; SUBUNIT VACCINE; TROVAX; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANTIGEN PRESENTING CELL; ARTICLE; BLOOD DONOR; CANCER IMMUNOTHERAPY; CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOLECULAR CLONING; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VIRUS RECOMBINANT;

CANCER VACCINES; CELL DIVISION; CELLS, CULTURED; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; GENES, MHC CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33645814017     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02338.x     Document Type: Article

References (19)

1. Van den Eynde BJ van der Bruggen P. T cell defined tumour antigens. Curr Opin Immunol 1997 9 684 93.
2. Wang RF Rosenberg SA. Human tumour antigens for cancer vaccine development. Immunol Rev 1999 170 85 100.
3. Jones H Roberts G Hole N McDicken IW Stern P. Investigation of expression of 5T4 antigen in cervical cancer. Br J Cancer 1990 61 96 100.
4. Southall PJ Boxer GM Bagshawe KD Hole N Bromley M Stern PL. Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 1990 61 89 95.
5. Starzynska T Rahi V Stern PL. The expression of 5T4 antigen in colorectal and gastric carcinoma. Br J Cancer 1992 66 867 9.
6. Wrigley E McGown A Rennison J Swindell R Crowther D Starzynska T Stern PL. 5T4 oncofetal antigen expression in ovarian carcinoma. Int J Gynecol Cancer 1995 5 269 74.
7. Starzynska T Wiechowska-Kozlowska A Marlicz K et al. 5T4 oncofetal antigen in gastric carcinoma and its clinical significance. Eur J Gastroenterol Hepatol 1998 10 479 84.
8. Carsberg CJ Myers KA Stern PL. Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells. Int J Cancer 1996 68 84 92.
9. Mulryan K Ryan MG Myers KA Shaw D Wang W Kingsman SM Stern PL Carroll MW. Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors. Mol Cancer Ther 2002 12 1129 37.
10. + T cell dependent and antibody mediated. Cancer Immunol Immunother 2005 Online publication: 2005 November 26, 1-10.q9
11. Steven NM Leese AM Annels NE Lee SP Rickinson AB. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J Exp Med 1996 184 1801 13.
12. Visseren MJ van Elsas A van der Voort EI Ressing ME Kast WM Schrier PI Melief CJ. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J Immunol 1995 154 3991 8.
13. van Elsas A van der Burg SH van der Minne CE Borghi M Mourer JS Melief CJ Schrier PI. Peptide-pulsed dendritic cells induce tumouricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. Eur J Immunol 1996 26 1683 9.
14. Pittet MJ Speiser DE Lienard D et al. Expansion and functional maturation of human tumour antigen-specific CD8 T cells after vaccination with antigenic peptide. Clin Cancer Res 2001 7 796s 803s.
15. Kao H Marto JA Hoffmann TK Shabanowitz J Finkelstein SD Whiteside TL Hunt DF Finn OJ. Identification of cyclin B1 as a shared human epithelial tumour-associated antigen recognized by T cells. J Exp Med 2001 194 1313 23.
16. Sallusto F Lenig D Forster R Lipp M Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401 708 12.
17. Yee C Savage PA Lee PP Davis MM Greenberg PD. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol 1999 162 2227 34.
18. Marsh S Parham P Barber L. The HLA class I and class II loci. In: Marsh SGE Parham P Barber LD, eds q10. The HLA Facts Book. San Diego, San Francisco, New York, Boston, London, Sydney, Tokyo Academic Press 2000 258.
19. Dionne SO Lake DF Grimes WJ Smith MH Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries. Immunogenetics 2004 56 391 8.